Selected research
Industry Research
Mammalian Cell Culture Service Industry Research Report 2026
Market perspective
The global Mammalian Cell Culture Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Mammalian Cell Culture Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Mammalian Cell Culture Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Mammalian Cell Culture Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Mammalian Cell Culture Service include ARVYS Proteins, Inc., Xell AG, BioXpedia, Biocompare, Sphere Fluidics, Huakan Bio, ABS Inc, Coriell Institute and BiBo Biopharma Engineering Co., LTD., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Mammalian Cell Culture Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mammalian Cell Culture Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mammalian Cell Culture Service Market by Company
ARVYS Proteins, Inc.
Xell AG
BioXpedia
Biocompare
Sphere Fluidics
Huakan Bio
ABS Inc
Coriell Institute
BiBo Biopharma Engineering Co., LTD.
Aurelia Bioscience
Rockland
Penn Genetics
Ningbo Mingzhou Biotechnology Co., Ltd.
Lonza
FUJIFILM Diosynth Biotechnologies
Shanghai Sunway Biotech
Lerner Research Institute
Cell Biologics
Cell Culture Company
Novartis
Nordmark Pharma GmbH
Mammalian Cell Culture Service Segment by Type
Primary Cells
Transformed Cells
Self-renewing Cells
Mammalian Cell Culture Service Segment by Application
Production of Vaccines
Production of Monoclonal Antibodies
Production of Therapeutic Proteins
Others
Mammalian Cell Culture Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mammalian Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mammalian Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mammalian Cell Culture Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mammalian Cell Culture Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Primary Cells
- Transformed Cells
- Self-renewing Cells
Applications
- Production of Vaccines
- Production of Monoclonal Antibodies
- Production of Therapeutic Proteins
- Others
Companies covered
- ARVYS Proteins, Inc.
- Xell AG
- BioXpedia
- Biocompare
- Sphere Fluidics
- Huakan Bio
- ABS Inc
- Coriell Institute
- BiBo Biopharma Engineering Co., LTD.
- Aurelia Bioscience
- Rockland
- Penn Genetics
- Ningbo Mingzhou Biotechnology Co., Ltd.
- Lonza
- FUJIFILM Diosynth Biotechnologies
- Shanghai Sunway Biotech
- Lerner Research Institute
- Cell Biologics
- Cell Culture Company
- Novartis
- Nordmark Pharma GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mammalian Cell Culture Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Primary Cells
- 2.2.3 Transformed Cells
- 2.2.4 Self-renewing Cells
- 2.3 Mammalian Cell Culture Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Production of Vaccines
- 2.3.3 Production of Monoclonal Antibodies
- 2.3.4 Production of Therapeutic Proteins
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Mammalian Cell Culture Service Breakdown Data by Type
- 3.1 Global Mammalian Cell Culture Service Historic Market Size by Type (2021-2026)
- 3.2 Global Mammalian Cell Culture Service Forecasted Market Size by Type (2027-2032)
4 Mammalian Cell Culture Service Breakdown Data by Application
- 4.1 Global Mammalian Cell Culture Service Historic Market Size by Application (2021-2026)
- 4.2 Global Mammalian Cell Culture Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mammalian Cell Culture Service Market Perspective (2021-2032)
- 5.2 Global Mammalian Cell Culture Service Growth Trends by Region
- 5.2.1 Global Mammalian Cell Culture Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mammalian Cell Culture Service Historic Market Size by Region (2021-2026)
- 5.2.3 Mammalian Cell Culture Service Forecasted Market Size by Region (2027-2032)
- 5.3 Mammalian Cell Culture Service Market Dynamics
- 5.3.1 Mammalian Cell Culture Service Industry Trends
- 5.3.2 Mammalian Cell Culture Service Market Drivers
- 5.3.3 Mammalian Cell Culture Service Market Challenges
- 5.3.4 Mammalian Cell Culture Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mammalian Cell Culture Service Players by Revenue
- 6.1.1 Global Top Mammalian Cell Culture Service Players by Revenue (2021-2026)
- 6.1.2 Global Mammalian Cell Culture Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Mammalian Cell Culture Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mammalian Cell Culture Service Head Office and Area Served
- 6.4 Global Mammalian Cell Culture Service Players, Product Type & Application
- 6.5 Global Mammalian Cell Culture Service Manufacturers Established Date
- 6.6 Global Mammalian Cell Culture Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mammalian Cell Culture Service Market Size (2021-2032)
- 7.2 North America Mammalian Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 7.4 North America Mammalian Cell Culture Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mammalian Cell Culture Service Market Size (2021-2032)
- 8.2 Europe Mammalian Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 8.4 Europe Mammalian Cell Culture Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mammalian Cell Culture Service Market Size (2021-2032)
- 9.2 Asia-Pacific Mammalian Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mammalian Cell Culture Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mammalian Cell Culture Service Market Size (2021-2032)
- 10.2 South America Mammalian Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 10.4 South America Mammalian Cell Culture Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mammalian Cell Culture Service Market Size (2021-2032)
- 11.2 Middle East & Africa Mammalian Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mammalian Cell Culture Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ARVYS Proteins, Inc.
- 12.1.1 ARVYS Proteins, Inc. Company Information
- 12.1.2 ARVYS Proteins, Inc. Business Overview
- 12.1.3 ARVYS Proteins, Inc. Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.1.4 ARVYS Proteins, Inc. Mammalian Cell Culture Service Product Portfolio
- 12.1.5 ARVYS Proteins, Inc. Recent Developments
- 12.2 Xell AG
- 12.2.1 Xell AG Company Information
- 12.2.2 Xell AG Business Overview
- 12.2.3 Xell AG Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.2.4 Xell AG Mammalian Cell Culture Service Product Portfolio
- 12.2.5 Xell AG Recent Developments
- 12.3 BioXpedia
- 12.3.1 BioXpedia Company Information
- 12.3.2 BioXpedia Business Overview
- 12.3.3 BioXpedia Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.3.4 BioXpedia Mammalian Cell Culture Service Product Portfolio
- 12.3.5 BioXpedia Recent Developments
- 12.4 Biocompare
- 12.4.1 Biocompare Company Information
- 12.4.2 Biocompare Business Overview
- 12.4.3 Biocompare Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.4.4 Biocompare Mammalian Cell Culture Service Product Portfolio
- 12.4.5 Biocompare Recent Developments
- 12.5 Sphere Fluidics
- 12.5.1 Sphere Fluidics Company Information
- 12.5.2 Sphere Fluidics Business Overview
- 12.5.3 Sphere Fluidics Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.5.4 Sphere Fluidics Mammalian Cell Culture Service Product Portfolio
- 12.5.5 Sphere Fluidics Recent Developments
- 12.6 Huakan Bio
- 12.6.1 Huakan Bio Company Information
- 12.6.2 Huakan Bio Business Overview
- 12.6.3 Huakan Bio Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.6.4 Huakan Bio Mammalian Cell Culture Service Product Portfolio
- 12.6.5 Huakan Bio Recent Developments
- 12.7 ABS Inc
- 12.7.1 ABS Inc Company Information
- 12.7.2 ABS Inc Business Overview
- 12.7.3 ABS Inc Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.7.4 ABS Inc Mammalian Cell Culture Service Product Portfolio
- 12.7.5 ABS Inc Recent Developments
- 12.8 Coriell Institute
- 12.8.1 Coriell Institute Company Information
- 12.8.2 Coriell Institute Business Overview
- 12.8.3 Coriell Institute Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.8.4 Coriell Institute Mammalian Cell Culture Service Product Portfolio
- 12.8.5 Coriell Institute Recent Developments
- 12.9 BiBo Biopharma Engineering Co., LTD.
- 12.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
- 12.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview
- 12.9.3 BiBo Biopharma Engineering Co., LTD. Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.9.4 BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Product Portfolio
- 12.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
- 12.10 Aurelia Bioscience
- 12.10.1 Aurelia Bioscience Company Information
- 12.10.2 Aurelia Bioscience Business Overview
- 12.10.3 Aurelia Bioscience Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.10.4 Aurelia Bioscience Mammalian Cell Culture Service Product Portfolio
- 12.10.5 Aurelia Bioscience Recent Developments
- 12.11 Rockland
- 12.11.1 Rockland Company Information
- 12.11.2 Rockland Business Overview
- 12.11.3 Rockland Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.11.4 Rockland Mammalian Cell Culture Service Product Portfolio
- 12.11.5 Rockland Recent Developments
- 12.12 Penn Genetics
- 12.12.1 Penn Genetics Company Information
- 12.12.2 Penn Genetics Business Overview
- 12.12.3 Penn Genetics Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.12.4 Penn Genetics Mammalian Cell Culture Service Product Portfolio
- 12.12.5 Penn Genetics Recent Developments
- 12.13 Ningbo Mingzhou Biotechnology Co., Ltd.
- 12.13.1 Ningbo Mingzhou Biotechnology Co., Ltd. Company Information
- 12.13.2 Ningbo Mingzhou Biotechnology Co., Ltd. Business Overview
- 12.13.3 Ningbo Mingzhou Biotechnology Co., Ltd. Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.13.4 Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Product Portfolio
- 12.13.5 Ningbo Mingzhou Biotechnology Co., Ltd. Recent Developments
- 12.14 Lonza
- 12.14.1 Lonza Company Information
- 12.14.2 Lonza Business Overview
- 12.14.3 Lonza Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.14.4 Lonza Mammalian Cell Culture Service Product Portfolio
- 12.14.5 Lonza Recent Developments
- 12.15 FUJIFILM Diosynth Biotechnologies
- 12.15.1 FUJIFILM Diosynth Biotechnologies Company Information
- 12.15.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 12.15.3 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.15.4 FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Product Portfolio
- 12.15.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 12.16 Shanghai Sunway Biotech
- 12.16.1 Shanghai Sunway Biotech Company Information
- 12.16.2 Shanghai Sunway Biotech Business Overview
- 12.16.3 Shanghai Sunway Biotech Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.16.4 Shanghai Sunway Biotech Mammalian Cell Culture Service Product Portfolio
- 12.16.5 Shanghai Sunway Biotech Recent Developments
- 12.17 Lerner Research Institute
- 12.17.1 Lerner Research Institute Company Information
- 12.17.2 Lerner Research Institute Business Overview
- 12.17.3 Lerner Research Institute Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.17.4 Lerner Research Institute Mammalian Cell Culture Service Product Portfolio
- 12.17.5 Lerner Research Institute Recent Developments
- 12.18 Cell Biologics
- 12.18.1 Cell Biologics Company Information
- 12.18.2 Cell Biologics Business Overview
- 12.18.3 Cell Biologics Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.18.4 Cell Biologics Mammalian Cell Culture Service Product Portfolio
- 12.18.5 Cell Biologics Recent Developments
- 12.19 Cell Culture Company
- 12.19.1 Cell Culture Company Company Information
- 12.19.2 Cell Culture Company Business Overview
- 12.19.3 Cell Culture Company Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.19.4 Cell Culture Company Mammalian Cell Culture Service Product Portfolio
- 12.19.5 Cell Culture Company Recent Developments
- 12.20 Novartis
- 12.20.1 Novartis Company Information
- 12.20.2 Novartis Business Overview
- 12.20.3 Novartis Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.20.4 Novartis Mammalian Cell Culture Service Product Portfolio
- 12.20.5 Novartis Recent Developments
- 12.21 Nordmark Pharma GmbH
- 12.21.1 Nordmark Pharma GmbH Company Information
- 12.21.2 Nordmark Pharma GmbH Business Overview
- 12.21.3 Nordmark Pharma GmbH Revenue in Mammalian Cell Culture Service Business (2021-2026)
- 12.21.4 Nordmark Pharma GmbH Mammalian Cell Culture Service Product Portfolio
- 12.21.5 Nordmark Pharma GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst